{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:48:26Z","timestamp":1790790506671,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Kidney J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/ckj\/sfw091","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T00:55:03Z","timestamp":1476406503000},"page":"788-793","source":"Crossref","is-referenced-by-count":29,"title":["Treatment with rituximab in idiopathic membranous nephropathy"],"prefix":"10.1093","volume":"9","author":[{"given":"Marco","family":"Fiorentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tondolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grandaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Manno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"2017012505351248000_9.6.788.1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04321007"},{"key":"2017012505351248000_9.6.788.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01288.x"},{"key":"2017012505351248000_9.6.788.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.05.007"},{"key":"2017012505351248000_9.6.788.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh618"},{"key":"2017012505351248000_9.6.788.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-008-8074-1"},{"key":"2017012505351248000_9.6.788.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000071511.35221.B3"},{"key":"2017012505351248000_9.6.788.7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012020181"},{"key":"2017012505351248000_9.6.788.8","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0357-8"},{"key":"2017012505351248000_9.6.788.9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012010058"},{"key":"2017012505351248000_9.6.788.10","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.9"},{"key":"2017012505351248000_9.6.788.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0270-9295(03)00051-2"},{"key":"2017012505351248000_9.6.788.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041484.x"},{"key":"2017012505351248000_9.6.788.13","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01180307"},{"key":"2017012505351248000_9.6.788.14","doi-asserted-by":"publisher","DOI":"10.1159\/000327611"},{"key":"2017012505351248000_9.6.788.15","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01730408"},{"key":"2017012505351248000_9.6.788.16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07570712"},{"key":"2017012505351248000_9.6.788.17","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012060602"},{"key":"2017012505351248000_9.6.788.18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002231"},{"key":"2017012505351248000_9.6.788.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009080861"},{"key":"2017012505351248000_9.6.788.20","doi-asserted-by":"publisher","DOI":"10.1159\/000430849"},{"key":"2017012505351248000_9.6.788.21","doi-asserted-by":"crossref","unstructured":"Ruggenenti P , Debiec H , Ruggiero B et al . Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol 2015","DOI":"10.1681\/ASN.2014070640"},{"key":"2017012505351248000_9.6.788.22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010111125"},{"key":"2017012505351248000_9.6.788.23","doi-asserted-by":"crossref","unstructured":"Dahan K , Debiec H , Plaisier E et al . Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol 2016","DOI":"10.1681\/ASN.2016040449"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/9\/6\/788\/8511205\/sfw091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T15:40:16Z","timestamp":1568475616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article-lookup\/doi\/10.1093\/ckj\/sfw091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,12,17]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1093\/ckj\/sfw091"],"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfw091","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]}}}